Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $9.39 Million - $10.9 Million
-175,000 Reduced 19.54%
720,400 $44.9 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $35.6 Million - $41.7 Million
602,100 Added 205.28%
895,400 $53 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $9.09 Million - $9.9 Million
-146,900 Reduced 33.37%
293,300 $19.4 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $33.9 Million - $38.1 Million
-571,100 Reduced 56.47%
440,200 $27.8 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $4.35 Million - $4.93 Million
75,400 Added 8.06%
1,011,300 $62.7 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $3.03 Million - $3.35 Million
-52,700 Reduced 5.33%
935,900 $56.4 Million
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $31.3 Million - $36.5 Million
570,100 Added 136.22%
988,600 $58.1 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $38.3 Million - $55.7 Million
-825,800 Reduced 66.37%
418,500 $23.3 Million
Q4 2019

Feb 12, 2020

BUY
$49.21 - $64.19 $25.4 Million - $33.1 Million
516,300 Added 70.92%
1,244,300 $79.9 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $30.4 Million - $36.1 Million
711,600 Added 4339.02%
728,000 $36.9 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $5.96 Million - $6.59 Million
-133,600 Reduced 89.07%
16,400 $744,000
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $3.78 Million - $4.5 Million
83,700 Added 126.24%
150,000 $7.16 Million
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $8.96 Million - $11.6 Million
-183,700 Reduced 73.48%
66,300 $3.45 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $11.6 Million - $12.6 Million
-193,500 Reduced 43.63%
250,000 $15.3 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $10.1 Million - $11.6 Million
182,500 Added 69.92%
443,500 $28.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
261,000
261,000 $14.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.